<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">35156504</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>02</Month>
        <Day>23</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>02</Month>
        <Day>24</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1521-0464</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>29</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>Drug delivery</Title>
          <ISOAbbreviation>Drug Deliv</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Multifunctional liposome for photoacoustic/ultrasound imaging-guided chemo/photothermal retinoblastoma therapy.</ArticleTitle>
        <Pagination>
          <StartPage>519</StartPage>
          <EndPage>533</EndPage>
          <MedlinePgn>519-533</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/10717544.2022.2032876</ELocationID>
        <Abstract>
          <AbstractText>Retinoblastoma (RB) is a malignant intraocular neoplasm that occurs in children. Diagnosis and therapy are frequently delayed, often leading to metastasis, which necessitates effective imaging and treatment. In recent years, the use of nanoplatforms allowing both imaging and targeted treatment has attracted much attention. Herein, we report a novel nanoplatform folate-receptor (FR) targeted laser-activatable liposome termed FA-DOX-ICG-PFP@Lip, which is loaded with doxorubicin (DOX)/indocyanine green (ICG) and liquid perfluoropentane (PFP) for photoacoustic/ultrasound (PA/US) dual-modal imaging-guided chemo/photothermal RB therapy. The dual-modal imaging capability, photothermal conversion under laser irradiation, biocompatibility, and antitumor ability of these liposomes were appraised. The multifunctional liposome showed a good tumor targeting ability and was efficacious as a dual-modality contrast agent both <i>in vivo</i> and <i>in vitro</i>. When laser-irradiated, the liposome converted light energy to heat. This action caused immediate destruction of tumor cells, while simultaneously initiating PFP phase transformation to release DOX, resulting in both photothermal and chemotherapeutic antitumor effects. Notably, the FA-DOX-ICG-PFP@Lip showed good biocompatibility and no systemic toxicity was observed after laser irradiation in RB tumor-bearing mice. Hence, the FA-DOX-ICG-PFP@Lip shows great promise for dual-modal imaging-guided chemo/photothermal therapy, and may have significant value for diagnosing and treating RB.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Meng</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Clinical Laboratory, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, PR China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Clinical Laboratory Diagnostics (Ministry of Education), College of Laboratory Medicine, Chongqing Medical University, Chongqing, PR China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bian</LastName>
            <ForeName>Xintong</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Clinical Laboratory, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, PR China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Clinical Laboratory Diagnostics (Ministry of Education), College of Laboratory Medicine, Chongqing Medical University, Chongqing, PR China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Xu</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Clinical Laboratory, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, PR China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Zhongshan Ophthalmic Center, State Key Laboratory of Ophthalmology, Sun Yat-sen University, Guangzhou, PR China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fan</LastName>
            <ForeName>Ningke</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Clinical Laboratory Diagnostics (Ministry of Education), College of Laboratory Medicine, Chongqing Medical University, Chongqing, PR China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zou</LastName>
            <ForeName>Hongmi</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Ophthalmology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, PR China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bao</LastName>
            <ForeName>Yixi</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Clinical Laboratory, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, PR China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhou</LastName>
            <ForeName>Yu</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Ophthalmology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, PR China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Drug Deliv</MedlineTA>
        <NlmUniqueID>9417471</NlmUniqueID>
        <ISSNLinking>1071-7544</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000903">Antibiotics, Antineoplastic</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D004396">Coloring Agents</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D004337">Drug Carriers</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D058972">Folic Acid Transporters</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D008081">Liposomes</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>80168379AG</RegistryNumber>
          <NameOfSubstance UI="D004317">Doxorubicin</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>IX6J1063HV</RegistryNumber>
          <NameOfSubstance UI="D007208">Indocyanine Green</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000903" MajorTopicYN="N">Antibiotics, Antineoplastic</DescriptorName>
          <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002470" MajorTopicYN="N">Cell Survival</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002626" MajorTopicYN="N">Chemistry, Pharmaceutical</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004396" MajorTopicYN="N">Coloring Agents</DescriptorName>
          <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004317" MajorTopicYN="N">Doxorubicin</DescriptorName>
          <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004337" MajorTopicYN="N">Drug Carriers</DescriptorName>
          <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D065546" MajorTopicYN="N">Drug Liberation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D058972" MajorTopicYN="N">Folic Acid Transporters</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007208" MajorTopicYN="N">Indocyanine Green</DescriptorName>
          <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008081" MajorTopicYN="N">Liposomes</DescriptorName>
          <QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D053758" MajorTopicYN="N">Nanoparticles</DescriptorName>
          <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010316" MajorTopicYN="N">Particle Size</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D061088" MajorTopicYN="N">Photoacoustic Techniques</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000082703" MajorTopicYN="N">Photothermal Therapy</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011897" MajorTopicYN="N">Random Allocation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019572" MajorTopicYN="N">Retinal Neoplasms</DescriptorName>
          <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012175" MajorTopicYN="N">Retinoblastoma</DescriptorName>
          <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013499" MajorTopicYN="N">Surface Properties</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018084" MajorTopicYN="N">Ultrasonography, Interventional</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D023041" MajorTopicYN="N">Xenograft Model Antitumor Assays</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Nanoplatform</Keyword>
        <Keyword MajorTopicYN="N">doxorubicin</Keyword>
        <Keyword MajorTopicYN="N">dual-modal imaging</Keyword>
        <Keyword MajorTopicYN="N">photothermal therapy</Keyword>
        <Keyword MajorTopicYN="N">retinoblastoma</Keyword>
      </KeywordList>
      <CoiStatement>The authors have declared that no competing interest exists.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>14</Day>
          <Hour>8</Hour>
          <Minute>52</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>15</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>24</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35156504</ArticleId>
        <ArticleId IdType="pmc">PMC8863383</ArticleId>
        <ArticleId IdType="doi">10.1080/10717544.2022.2032876</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Ahmad F, Wang X, Jiang Z, et al.  (2019). Codoping enhanced radioluminescence of nanoscintillators for X-ray-activated synergistic cancer therapy and prognosis using metabolomics. ACS Nano
13:10419–33.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31430127</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Assaraf YG, Leamon CP, Reddy JA. (2014). The folate receptor as a rational therapeutic target for personalized cancer treatment. Drug Resist Updat
17:89–95.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25457975</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Björnmalm M, Thurecht KJ, Michael M, et al.  (2017). Bridging bio-nano science and cancer nanomedicine. ACS Nano
11:9594–613.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28926225</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Broaddus E, Topham A, Singh AD. (2009). Survival with retinoblastoma in the USA: 1975–2004. Br J Ophthalmol
93:24–7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18718969</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Burke BP, Cawthorne C, Archibald SJ. (2017). Multimodal nanoparticle imaging agents: design and applications. Philos Trans A Math Phys Eng Sci
375:20170261.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29038384</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Canturk S, Qaddoumi I, Khetan V, et al.  (2010). Survival of retinoblastoma in less-developed countries impact of socioeconomic and health-related indicators. Br J Ophthalmol
94:1432–6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20733021</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chawla B, Hasan F, Azad R, et al.  (2016). Clinical presentation and survival of retinoblastoma in Indian children. Br J Ophthalmol
100:172–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26061162</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen C, Ke J, Zhou XE, et al.  (2013). Structural basis for molecular recognition of folic acid by folate receptors. Nature
500:486–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5797940</ArticleId>
            <ArticleId IdType="pubmed">23851396</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen J, Ding J, Wang Y, et al.  (2017). Sequentially responsive shell-stacked nanoparticles for deep penetration into solid tumors. Adv Mater 29.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28632302</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen ML, John M, Lee SL, Tyner KM. (2017). Development considerations for nanocrystal drug products. AAPS J
19:642–51.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28281194</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cheng X, Li H, Chen Y, et al.  (2013). Ultrasound-triggered phase transition sensitive magnetic fluorescent nanodroplets as a multimodal imaging contrast agent in rat and mouse model. PLOS One
8:e85003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3877337</ArticleId>
            <ArticleId IdType="pubmed">24391983</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cherukuri P, Glazer ES, Curley SA. (2010). Targeted hyperthermia using metal nanoparticles. Adv Drug Deliv Rev
62:339–45.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2827640</ArticleId>
            <ArticleId IdType="pubmed">19909777</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Durot I, Wilson SR, Willmann JK. (2018). Contrast-enhanced ultrasound of malignant liver lesions. Abdom Radiol
43:819–47.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29094174</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Feindel W, Yamamoto YL, Hodge P. (1967). The human cerebral microcirculation studied by intra-arterial radio-active tracers, Coomassie Blue and fluorescein dyes. Bibl Anat
9:220–4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">4961774</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guo Y, Ran Y, Wang Z, et al.  (2019). Magnetic-responsive and targeted cancer nanotheranostics by PA/MR bimodal imaging-guided photothermally triggered immunotherapy. Biomaterials
219:119370.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31357006</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>He H, Markoutsa E, Zhan Y, et al.  (2017). Mussel-inspired PLGA/polydopamine core-shell nanoparticle for light induced cancer thermochemotherapy. Acta Biomater
59:181–91.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5551691</ArticleId>
            <ArticleId IdType="pubmed">28688985</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hu D, Liu C, Song L, et al.  (2016). Indocyanine green-loaded polydopamine-iron ions coordination nanoparticles for photoacoustic/magnetic resonance dual-modal imaging-guided cancer photothermal therapy. Nanoscale
8:17150–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27539790</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Iwamoto T. (2013). Clinical application of drug delivery systems in cancer chemotherapy: review of the efficacy and side effects of approved drugs. Biol Pharm Bull
36:715–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23649331</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jinsui Y, Bing S, Muhua L, et al.  (2018). Carboxymethyl-hexanoyl chitosan nanodroplets for ultrasonic imaging and drug delivery to tumor. Curr Pharm Des
24:1682–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29766795</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kalyane D, Raval N, Maheshwari R, et al.  (2019). Employment of enhanced permeability and retention effect (EPR): nanoparticle-based precision tools for targeting of therapeutic and diagnostic agent in cancer. Mater Sci Eng C Mater Biol Appl
98:1252–76.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30813007</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kansara V, Paturi D, Luo S, et al.  (2008). Folic acid transport via high affinity carrier-mediated system in human retinoblastoma cells. Int J Pharm
355:210–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4516230</ArticleId>
            <ArticleId IdType="pubmed">18207340</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim D, Yu MK, Lee TS, et al.  (2011). Amphiphilic polymer-coated hybrid nanoparticles as CT/MRI dual contrast agents. Nanotechnology
22:155101.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21389582</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kivelä T. (2009). The epidemiological challenge of the most frequent eye cancer: retinoblastoma, an issue of birth and death. Br J Ophthalmol
93:1129–31.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19704035</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kuo WS, Chang YT, Cho KC, et al.  (2012). Gold nanomaterials conjugated with indocyanine green for dual-modality photodynamic and photothermal therapy. Biomaterials
33:3270–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22289264</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee JH, Kim JW, Cheon J. (2013). Magnetic nanoparticles for multi-imaging and drug delivery. Mol Cells
35:274–84.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3887886</ArticleId>
            <ArticleId IdType="pubmed">23579479</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lesiak P, Bednarska K, Lewandowski W, et al.  (2019). Self-organized, one-dimensional periodic structures in a gold nanoparticle-doped nematic liquid crystal composite. ACS Nano
13:10154–60.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31433620</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li L, Fu J, Wang X, et al.  (2021). Biomimetic "Nanoplatelets" as a targeted drug delivery platform for breast cancer theranostics. ACS Appl Mater Interfaces
13:3605–21.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33449625</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>MacCarthy A, Birch JM, Draper GJ, et al.  (2009). Retinoblastoma: treatment and survival in Great Britain 1963 to 2002. Br J Ophthalmol
93:38–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18838414</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Matsuzaki M, Haruna M, Ota E, et al.  (2008). Dietary folate intake, use of folate supplements, lifestyle factors, and serum folate levels among pregnant women in Tokyo, Japan. J Obstet Gynaecol Res
34:971–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19012695</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nel AE, Mädler L, Velegol D, et al.  (2009). Understanding biophysicochemical interactions at the nano-bio interface. Nat Mater
8:543–57.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19525947</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pandey AN. (2014). Retinoblastoma: an overview. Saudi J Ophthalmol
28:310–5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4250503</ArticleId>
            <ArticleId IdType="pubmed">25473349</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pérez-Herrero E, Fernández-Medarde A. (2015). Advanced targeted therapies in cancer: drug nanocarriers, the future of chemotherapy. Eur J Pharm Biopharm
93:52–79.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25813885</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Redolfi Riva E, Desii A, Sinibaldi E, et al.  (2014). Gold nanoshell/polysaccharide nanofilm for controlled laser-assisted tissue thermal ablation. ACS Nano
8:5552–63.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24797875</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schleder S, Janke M, Agha A, et al.  (2015). Preoperative differentiation of thyroid adenomas and thyroid carcinomas using high resolution contrast-enhanced ultrasound (CEUS). Clin Hemorheol Microcirc
61:13–22.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24898562</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sun T, Zhang YS, Pang B, et al.  (2014). Engineered nanoparticles for drug delivery in cancer therapy. Angew Chem Int Ed Engl
53:12320–64.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25294565</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tartaro K, VanVolkenburg M, Wilkie D, et al.  (2015). Development of a fluorescence-based in vivo phagocytosis assay to measure mononuclear phagocyte system function in the rat. J Immunotoxicol
12:239–46.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25027674</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Toffoli G, Cernigoi C, Russo A, et al.  (1997). Overexpression of folate binding protein in ovarian cancers. Int J Cancer
74:193–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9133455</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang L, Chen S, Zhu Y, et al.  (2018). Triple-modal imaging-guided chemo-photothermal synergistic therapy for breast cancer with magnetically targeted phase-shifted nanoparticles. ACS Appl Mater Interfaces
10:42102–14.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30431261</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang S, Huang P, Chen X. (2016). Hierarchical targeting strategy for enhanced tumor tissue accumulation/retention and cellular internalization. Adv Mater
28:7340–64.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5014563</ArticleId>
            <ArticleId IdType="pubmed">27255214</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang S, Lin J, Wang T, et al.  (2016). Recent advances in photoacoustic imaging for deep-tissue biomedical applications. Theranostics
6:2394–413.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5118603</ArticleId>
            <ArticleId IdType="pubmed">27877243</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Y, Wei G, Zhang X, et al.  (2018). Multistage targeting strategy using magnetic composite nanoparticles for synergism of photothermal therapy and chemotherapy. Small
14:e1702994.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29205795</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu J, Williams GR, Niu S, et al.  (2019). A multifunctional biodegradable nanocomposite for cancer theranostics. Adv Sci
6:1802001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6661946</ArticleId>
            <ArticleId IdType="pubmed">31380200</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xiang LH, Yao MH, Xu G, et al.  (2017). Diagnostic value of contrast-enhanced ultrasound and shear-wave elastography for breast lesions of sub-centimeter. Clin Hemorheol Microcirc
67:69–80.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28482623</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xie Y, Wang J, Wang Z, et al.  (2018). Perfluorocarbon-loaded polydopamine nanoparticles as ultrasound contrast agents. Nanoscale
10:12813–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6319376</ArticleId>
            <ArticleId IdType="pubmed">29947626</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang J, Vlashi E, Low P. (2012). Folate-linked drugs for the treatment of cancer and inflammatory diseases. Subcell Biochem
56:163–79.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22116699</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang P, Li D, Jin S, et al.  (2014). Stimuli-responsive biodegradable poly(methacrylic acid) based nanocapsules for ultrasound traced and triggered drug delivery system. Biomaterials
35:2079–88.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24331704</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang N, Li J, Hou R, et al.  (2017). Bubble-generating nano-lipid carriers for ultrasound/CT imaging-guided efficient tumor therapy. Int J Pharm
534:251–62.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28803939</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang N, Song J, Liu Y, et al.  (2019). Photothermal therapy mediated by phase-transformation nanoparticles facilitates delivery of anti-PD1 antibody and synergizes with antitumor immunotherapy for melanoma. J Control Release
306:15–28.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31132380</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang Y, Yong L, Luo Y, et al.  (2019). Enhancement of HIFU ablation by sonosensitizer-loading liquid fluorocarbon nanoparticles with pre-targeting in a mouse model. Sci Rep
9:6982.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6502828</ArticleId>
            <ArticleId IdType="pubmed">31061456</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao LY, Chao X, Yang BS, et al.  (2021). Phase-shift perfluoropentane nanoemulsions enhance pulsed high-intensity focused ultrasound ablation in an isolated perfused liver system and their potential value for cancer therapy. J Ultrasound Med
41:107–21.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33724514</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zheng C, Zheng M, Gong P, et al.  (2012). Indocyanine green-loaded biodegradable tumor targeting nanoprobes for in vitro and in vivo imaging. Biomaterials
33:5603–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22575835</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhu H, Li J, Qi X, et al.  (2018). Oxygenic hybrid semiconducting nanoparticles for enhanced photodynamic therapy. Nano Lett
18:586–94.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29220576</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
